Galway Biomedical underscores its ambition of creating new jobs and further positioning Galway as a global hub for medtech innovation.
Galway Biomedical has opened a new state-of-the-art facility at Ballybrit Business Park in Galway, marking a significant expansion for the medical device contract manufacturer.
The company, which develops and manufactures medical device components for vascular, dental, orthopaedic, urology, and general surgery applications, recently closed an oversubscribed Series A investment round with backing from the Western Development Commission (WDC), Enterprise Ireland (EI), and private medical device veteran investors.
“Galway is recognised as a centre of excellence along with other global regions such as the Bay Area in California, Minneapolis, and Boston metropolitan areas”
The 13,000 square foot facility at Ballybrit Business Park is strategically located in the centre of Galway’s medical device ecosystem. A significant feature of the development includes the construction of a 4,000 square foot ISO Class 7/8 cleanroom, which the company states will place it above global competitors in terms of facility design and capability.
Powering regional development
Minister for Rural and Community Development & the Gaeltacht, Dara Calleary, TD, who performed the ribbon-cutting ceremony, praised the development as “a great boost to Galway and Ireland,” highlighting the west of Ireland’s established reputation for excellence and innovation in life sciences.
“This is particularly good news for the west of Ireland where we are now well established as leaders in the life sciences sector and have a reputation for excellence and innovation,” said Calleary. “Galway Biomedical’s plans to invest is fantastic. I am confident the team will find top talent to fill the new jobs planned.”
Conan Campbell, CEO and Founder of Galway Biomedical, said that company intends to build a global reputation as a dependable and responsive partner for the development and commercialisation of cutting edge implantable medical devices.
He explained the significance of the company name and location: “We chose the name Galway Biomedical for this new venture because of the reputation Galway has in the medical device industry. It is recognised as a centre of excellence along with other global regions such as the Bay Area in California, Minneapolis, and Boston metropolitan areas.”
Campbell added: “Our aim is to bolster that reputation by making the name of the city we proudly carry in our name even more synonymous with medical device excellence. We will do this by creating a first-class facility with a highly skilled workforce from an exceptional pool of talent in Galway.”
Campbell said that the recent successful Series A funding round will accelerate the company’s growth momentum through team expansion and enhanced capabilities.
“We appreciate the trust put in us and intend to repay it by ensuring that our shareholders receive a significant return on their investment, but also by ensuring that Galway Biomedical strives relentlessly to enhance the reputation of Ireland as a world-class centre for medical device excellence in innovation and manufacturing.”
Minister for Enterprise, Tourism and Employment, Peter Burke T.D, emphasised the government’s commitment to technological innovation and employment growth, noting that “Galway Biomedical is at the forefront of innovation, developing best in class solutions to meet the needs of the global healthcare sector. I’d like to congratulate Conan and the team on today’s new state-of-the-art facility opening and the plans to create high quality jobs here in Galway.
“Today’s announcement paves the way for this innovative medtech company to grow and scale. The Government, through Enterprise Ireland, looks forward to continued engagement with Galway Biomedical to support the growth of the business into the future.”
Expansion plans
With its strategic location, advanced facilities, and strong governmental and investor support, Galway Biomedical is positioned to become a significant player in the global medical device manufacturing landscape while creating substantial economic benefits for the west of Ireland.
2025 will be a landmark year for Galway Biomedical as it continues the extensive fit-out of the facility and plans to add new technologies to support its manufacturing capabilities.
Within the 13,000 square foot facility Galway Biomedical are constructing a 4,000 square foot ISO Class 7/8 cleanroom which will ensure it stands above its global competitors in terms of facility design and capability. The company also plans to add new technologies to support its manufacturing capabilities, enabling customers to pioneer advancements in medicine
Allan Mulrooney, CEO at The Western Development Commission, highlighted the regional impact: “Strengthening regional enterprise development is a central focus for The Western Development Commission, and we warmly welcome the ambitious expansion plans announced by Galway Biomedical following the close of the Series A funding round which will create high-value new jobs in Galway.”
Enterprise Ireland’s Tom Cusack, Divisional Manager for Industrial and Lifesciences, commended “the ambition of this indigenous company to compete at the highest level, through their design, development and manufacturing capabilities in the US, Asia and Europe.”
-
Bank of Ireland is welcoming new customers every day – funding investments, working capital and expansions across multiple sectors. To learn more, click here
-
For support in challenging times, click here
-
Listen to the ThinkBusiness Podcast for business insights and inspiration. All episodes are here. You can also listen to the Podcast on:
-
Spotify
-
SoundCloud
-
Apple
